Menu

Experience

Phil Mitchell

    • Biotech Company ViaCyte to Be Acquired by Vertex Pharmaceuticals 


    • Cytokinetics – $450 Million Convertible Senior Notes Offering 


    • Sixth Street Invests in Blueprint Medicines 


    • Bristol Myers Squibb to Acquire Turning Point Therapeutics for $4.1 Billion 


    • General Catalyst Leads Eleanor Health’s $50 Million Series C  


    • Biote Agrees to Combine With SPAC Haymaker Acquisition Corp. III 


    • Arena Pharmaceuticals Agrees to Sell to Pfizer for $6.7 Billion 


    • Alvotech Agrees to Merge With SPAC Oaktree Acquisition Corp. II 


    • Baylis Medical Agrees to Sell to Boston Scientific for $1.75 Billion 


    • Flexion Therapeutics Agrees to Sell to Pacira BioSciences 


    • Warby Parker – Direct Listing 


    • ZOLL Medical Agrees to Acquire Itamar Medical for $538 Million 


    • Vividion Therapeutics Agrees to Sell to Bayer for up to $2 Billion 


    • Lyell Immunopharma – $425 Million IPO 


    • Cedar Cares Agrees to Acquire OODA Health 


    • Pan Pacific International Holdings Agrees to Acquire Gelson's  


    • Horizon Therapeutics to Acquire Viela Bio 


    • Celularity to Go Public Through SPAC Merger 


    • Olive Closes $225 Million Financing, Acquires Verata Health 


    • Ovid - $75 Million IPO 


    • VelosBio Agrees to Sell to Merck for $2.75 Billion 


    • AppHarvest to Combine With Novus Capital, a Special Purpose Acquisition Company 


    • Forbius Agrees to Sell to Bristol Myers Squibb 


    • ArcherDX Agrees to Combine With Invitae in $2.7 Billion Deal 


    • Avidity Biosciences - $289 Million IPO 


    • Vaxcyte - $288 Million IPO 


    • Reata Pharmaceuticals – $505 Million Follow-On Offering 


    • argenx – $557 Million Follow-On Offering 


    • Innate Pharma - $79 Million IPO 


    • Vir Biotechnology - $143 Million IPO 


    • ERYTECH – $144 Million IPO 


    • Cooley Advises on Nightstar + NuCana IPOs 


    • Aridis – $26 Million IPO 


    • Advaxis – $30 Million Registered Direct Offering 


    • Recro Pharma – $15 Million Follow-On  


    • Gemphire Therapeutics – $30 Million IPO 


    • Syros – $58 Million IPO 


    • Syros IPO – $58 Million 


    • Selecta Biosciences – $74 Million IPO 


    • Oncobiologics – $40 Million IPO and Private Placement 


    • Inotek Pharmaceuticals – $50 Million Follow-On 


    • Auxogyn and Fertility Authority Announce Merger 


    • AveXis – $95 Million IPO 


    • WAVE Life Sciences - $102 Million IPO 


    • Voyager Therapeutics - $80.5 Million IPO 


    • Strongbridge Biopharma IPO 


    • Aclaris Therapeutics IPO 


    • NantKwest IPO - $238 Million IPO 


    • ProNAi Therapeutics - $158 Million IPO 


    • Chiasma Completes $117 Million IPO 


    • Celyad Completes IPO 


    • NantKwest – $238 Million IPO 


    • Catabasis Completes $69 Million IPO 


    • ProNAi – $158 Million IPO 


    • MINDBODY Completes $100 Million IPO 


    • MINDBODY Completes $100 Million IPO 


    • HTG Completes its Initial Public Offering 


    • Aduro Completes $137 Million IPO 


    • KemPharm Completes its IPO 


    • Cidara Completes Initial Public Offering  


    • Invitae Completes $117 Million Initial Public Offering  


    • Ascendis Pharma closes $124 million IPO 


    • Bellicum Pharmaceuticals $160 million IPO 


    • TRACON Pharmaceuticals Completes Initial Public Offering 


    • DBV Technologies Completes Concurrent Public Offerings 


    • Sientra Completes $75 Million Initial Public Offering 


    • Demira Prices $125 Million IPO 


    • T2 Biosystems IPO 


    • Vitae Pharmaceuticals Completes Initial Public Offering  


    • Otonomy $100 Million IPO 


    • Immune Design $63 Million Initial Public Offering 


    • HealthEquity $146 Million Initial Public Offering 


    • Intersect ENT Initial Public Offering 


    • Minerva Neurosciences $32.7 Million IPO 


    • Kite Pharma $146 Million Initial Public Offering 


    • TriVascular Initial Public Offering 


    • Vital Therapies Initial Public Offering 


    • Cooley Advises Underwriters on Vital Therapies IPO 


    • Amedica Initial Public Offering 


    • Genocea Biosciences IPO 


    • Apollo Endosurgery Agreement Acquire Obesity Intervention Division of Allergan 


    • Minerva – $58 Million Follow-On Offering 


    • Merus IPO – $61 Million 


    • Bionano Genomics Initial Public Offering